Pharma.AI
End-to-end generative-AI platform spanning target discovery, molecular design and clinical-trial risk assessment for pharmaceutical research.
Find alternatives to Pharma.AI
No public pricing. The site describes 'flexible business models' (standalone technology access, or software combined with collaborative partnerships) and directs interested parties to contact the company — enterprise B2B, quote only.
What it does
- Drug discovery
How it compares
-
Recursion OS
Both platforms screen and design drug candidates with AI/ML; Insilico's own HKEX prospectus names Recursion in its Competitive Landscape table.
The table below shows the comparison of the major global AI pharmaceutical companies.
Regulatory filing · 18 Dec 2025
Sources
- Pricing
-
Official documentation · 4 Sep 2026
No price stated anywhere on the umbrella page; it offers 'Flexible Business Models' — standalone technology access, or software combined with Pharma.ai collaborations.
- Description
-
Official documentation · 4 Sep 2026
The site's own framing: 'Commercially-available end-to-end generative AI software and automation platform designed to improve the quality and productivity of pharmaceutical research.' Navigation lists the eight modules this umbrella spans — PandaOmics, Generative Biologics, Chemistry42, inClinico, Science42:DORA, PreciousGPT, Nach01, MMAI Gym — seven of which are their own records.
- Sold within
-
Pharma.AI's site offers "Flexible Business Models" ("Choose stand alone technology access or combine our software with Pharma.ai collaborations for a data-driven AI-partnership.") and a "Contact Us" route; no price or self-serve route is stated.
Also from Insilico Medicine
-
PandaOmics Platform
AI platform for therapeutic target identification, biomarker discovery, indication prioritization and drug repurposing over a multi-omics knowledge base.
-
PandaOmics Box Hardware
On-premise AI appliance running PandaOmics target and biomarker discovery locally with no external data transmission, sold in Server and Desktop editions.
-
Chemistry42 Platform
Generative small-molecule design platform combining de novo generation with physics-based methods, retrosynthesis, ADMET profiling and custom model training.
-
Biology42: Generative Biologics Platform
AI platform for de novo design and multi-property optimization of peptides, nanobodies and antibodies against specified targets and epitopes.
-
inClinico Application
Multimodal AI platform that forecasts the probability of success of individual clinical trials and scores alternative trial designs before implementation.
-
Science42: DORA Application
AI research writing assistant that drafts structured, cited papers, reviews, grant proposals and abstracts against biomedical databases such as PubMed and bioRxiv.
-
MMAI Gym Platform
Foundation-model training and benchmarking platform that fine-tunes a customer's own LLM on Insilico's proprietary pharma reasoning datasets and validates results in its automation lab.
Open Insilico Medicine in the directory
Something wrong here? Send a correction — quote this product id: insilico-medicine-pharma-ai.